Pfizer Announces It's Developing a COVID Vaccine Booster to Fight Against Delta Variant
"The first batch of the mRNA for the trial has already been manufactured at BioNTech's facility in Mainz, Germany," the companies said, adding it is anticipated that "the clinical studies to begin in August, subject to regulatory approvals."
The companies estimate that a third dose of the Pfizer vaccine will be needed 12 months after the first two doses.
Tropical Storm Elsa kills 1 in Florida, slams Georgia coast
Mourners, workers and media pay tribute to lives lost in Surfside condo collapse site
Yankees fan cries when GM calls with big news
Launching cars off 300-foot cliff is an annual tradition in this small town
Bernese mountain dog couldn't contain it's excitement when a new puppy arrived home
Search at Surfside condo collapse shifts from rescue to recovery as death toll rises
Lightning bolt strikes near One World Trade Center during severe weather
Ohio police chief resigns after putting KKK note on Black officer's desk
How to properly water trees to keep them alive
13 million people under tropical storm warning as Elsa rips through Florida coast
Death toll reaches 46 after Surfside rescue crews recover 10 more bodies
A nine-year-old makes 'America's Got Talent' history, jokes about Simon Cowell's wardrobe
What to be done about swim caps for Black hair being barred from Tokyo Olympic swim events
Bryson DeChambeau and Aaron Rodgers win The Match
Mike Bibby breaks down why NBA draft prospect Cade Cunningham will succeed at the next level
Eric Adams is in the lead to be NYC's next mayor, so who is the Democratic candidate?
She added, "Turning the corner on this pandemic, getting back to normal, and stopping the Delta variant requires all of us to do our part and to get vaccinated."
Post a Comment